These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7769804

  • 21. Endothelium-independent relaxations to acetylcholine and A23187 in the human umbilical artery.
    Xie H, Triggle CR.
    J Vasc Res; 1994; 31(2):92-105. PubMed ID: 8117864
    [Abstract] [Full Text] [Related]

  • 22. Age-related changes in vascular reactivity in genetically diabetic rats.
    Sexl V, Mancusi G, Raberger G, Schütz W.
    Pharmacology; 1995 Apr; 50(4):238-46. PubMed ID: 7792311
    [Abstract] [Full Text] [Related]

  • 23. In vitro and ex vivo inhibitory effects of L- and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta.
    Wang YX, Poon CI, Pang CC.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):112-9. PubMed ID: 8473999
    [Abstract] [Full Text] [Related]

  • 24. Influence of oxygen on endothelium-derived relaxing factor/nitric oxide and K(+)-dependent regulation of vascular tone.
    Vallet B, Winn MJ, Asante NK, Cain SM.
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):595-602. PubMed ID: 7528842
    [Abstract] [Full Text] [Related]

  • 25. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA, Gross SS, Rubin LE, Jaffe EA, Griffith OW, Levi R.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [Abstract] [Full Text] [Related]

  • 26. Acetylcholine- and flow-induced production and release of nitric oxide in arterial and venous endothelial cells.
    Fukaya Y, Ohhashi T.
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H99-106. PubMed ID: 8769739
    [Abstract] [Full Text] [Related]

  • 27. Time-dependent reduction of acetylcholine-induced relaxation in aortic rings of cholestatic rats.
    Rastegar H, Jorjani M, Roushanzamir F, Ahmadiani A, Namiranian K, Dehpour AR.
    Pharmacol Res; 2001 Dec; 44(6):519-25. PubMed ID: 11735360
    [Abstract] [Full Text] [Related]

  • 28. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration.
    Pieper GM.
    Diabetologia; 1999 Feb; 42(2):204-13. PubMed ID: 10064101
    [Abstract] [Full Text] [Related]

  • 29. Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits.
    Shukla N, Thompson CS, Angelini GD, Mikhailidis DP, Jeremy JY.
    Metabolism; 2004 Oct; 53(10):1315-21. PubMed ID: 15375788
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
    Thiemermann C, Mustafa M, Mester PA, Mitchell JA, Hecker M, Vane JR.
    Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
    [Abstract] [Full Text] [Related]

  • 31. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
    Münzel T, Li H, Mollnau H, Hink U, Matheis E, Hartmann M, Oelze M, Skatchkov M, Warnholtz A, Duncker L, Meinertz T, Förstermann U.
    Circ Res; 2000 Jan 07; 86(1):E7-E12. PubMed ID: 10625313
    [Abstract] [Full Text] [Related]

  • 32. Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic rats.
    Angulo J, Rodríguez-Mañas L, Peiró C, Neira M, Marín J, Sánchez-Ferrer CF.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov 07; 358(5):529-37. PubMed ID: 9840421
    [Abstract] [Full Text] [Related]

  • 33. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A, Swierkosz TA, Southan GJ, Hecker M, Vane JR.
    Br J Pharmacol; 1992 Dec 07; 107(4):1001-7. PubMed ID: 1281716
    [Abstract] [Full Text] [Related]

  • 34. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD, Paisley K, Martin W.
    Br J Pharmacol; 1993 Nov 07; 110(3):1003-8. PubMed ID: 7507774
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA, Narayanan K, Griffith OW, Kilbourn RG.
    Br J Pharmacol; 1995 Jun 07; 115(3):491-7. PubMed ID: 7582462
    [Abstract] [Full Text] [Related]

  • 36. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
    Zembowicz A, Hatchett RJ, Jakubowski AM, Gryglewski RJ.
    Br J Pharmacol; 1993 Sep 07; 110(1):151-8. PubMed ID: 7693274
    [Abstract] [Full Text] [Related]

  • 37. Endothelium-derived hyperpolarizing factor does not contribute to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic rats.
    Endo K, Abiru T, Machida H, Kasuya Y, Kamata K.
    Gen Pharmacol; 1995 Jan 07; 26(1):149-53. PubMed ID: 7713355
    [Abstract] [Full Text] [Related]

  • 38. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta.
    Pieper GM, Mei DA, Langenstroer P, O'Rourke ST.
    Am J Physiol; 1992 Sep 07; 263(3 Pt 2):H676-80. PubMed ID: 1415591
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of haemoglobin and N-nitro-L-arginine on constrictor and dilator responses of aortic rings from streptozotocin diabetic rats.
    Sikorski BW, Hodgson WC, King RG.
    Eur J Pharmacol; 1993 Oct 05; 242(3):275-82. PubMed ID: 8281991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.